Fairmount Funds Management LLC — 13F holdings

Fairmount Funds Management LLC reported 12 holdings worth $1.51B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. ORKA ORUKA THERAPEUTICS INC — $353M (23.3%)
2. DNTH Dianthus Therapeutics Inc — $247M (16.3%)
3. DMRA Damora Therapeutics Inc — $227M (15.0%)
4. COGT COGENT BIOSCIENCES INC — $213M (14.1%)
5. JBIO JADE BIOSCIENCES INC — $101M (6.7%)
6. ELVN ENLIVEN THERAPEUTICS INC — $94.2M (6.2%)
7. VRDN VIRIDIAN THERAPEUTICS INC — $93.5M (6.2%)
8. ZBIO ZENAS BIOPHARMA INC — $59.9M (4.0%)
9. CBIO CRESCENT BIOPHARMA INC. — $49.5M (3.3%)
10. APGE APOGEE THERAPEUTICS INC — $39.6M (2.6%)